RecruitingPhase 3NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Sponsor: Merck Sharp & Dohme LLCAurora, CO · Colorado Springs, CO · Greeley, CO · +51 more sites
RecruitingPhase 3NCT06561386A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Sponsor: Bristol-Myers SquibbGrand Junction, CO · Westminster, CO · +54 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAurora, CO · +1226 more sites